Efficacy and safety of ribosome-component immune modulator for preventing recurring respiratory infections in socialized children

Allergy Asthma Proc. 2013 Jan-Feb;34(1):108-9. doi: 10.2500/aap.2013.34.3643.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Child
  • Humans
  • Immunologic Factors / therapeutic use*
  • Logistic Models
  • Research Design
  • Respiratory Tract Infections / therapy*
  • Ribosomes / immunology*
  • Secondary Prevention
  • Socioeconomic Factors

Substances

  • Immunologic Factors